Dexamethasone intravitreal implant in the crystalline lens: a case report.
Elif ErtanReşat DumanRahmi DumanMustafa DoğanPublished in: Arquivos brasileiros de oftalmologia (2020)
This report describes the therapeutic effects and outcomes of an accidental injection of an intralenticular sustained-release dexamethasone implant (Ozurdex®) in three patients with diabetic macular edema. All three patients underwent accidental injections of sustained-release intravitreal dexamethasone implants into the crystalline lens by the same surgeon. After the accidental injection of Ozurdex® into the crystalline lens, a remarkable reduction in the macular edema and an improvement in visual acuity were observed, suggesting that a positive outcome can be achieved without immediate surgery.
Keyphrases
- diabetic retinopathy
- end stage renal disease
- high dose
- cataract surgery
- low dose
- room temperature
- ultrasound guided
- soft tissue
- age related macular degeneration
- vascular endothelial growth factor
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- peritoneal dialysis
- prognostic factors
- metabolic syndrome
- atrial fibrillation
- platelet rich plasma
- coronary artery disease
- glycemic control